| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/06/2008 | US20080274081 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 11/06/2008 | US20080274059 Mite fusion proteins |
| 11/06/2008 | US20080274050 Labelled Adrenomedullin Derivatives and Their Use for Imaging and Therapy |
| 11/06/2008 | US20080274045 Imaging, diagnosis and treatment of disease |
| 11/06/2008 | DE10138876B4 Genetisch modifizierte zyklisch-Nukleotid-gesteuerte lonenkanäle und deren Verwendung Genetically modified cyclic-nucleotide-gated ion channels, and their use |
| 11/06/2008 | CA2685756A1 Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis |
| 11/06/2008 | CA2685672A1 Truncated variant of the mammalian target for rapamycin (mtor) protein |
| 11/06/2008 | CA2685295A1 Hemipteran- and coleopteran- active toxin proteins from bacillus thuringiensis |
| 11/06/2008 | CA2685124A1 Products for altering il-33 activity and methods therefor |
| 11/06/2008 | CA2685115A1 Igf-1r binding proteins and antagonists |
| 11/06/2008 | CA2684742A1 V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity |
| 11/06/2008 | CA2684038A1 Plants having improved growth characteristics under reduced nutrient availability and a method for making the same |
| 11/06/2008 | CA2679658A1 Fusion proteins binding to growth factors |
| 11/06/2008 | CA2676809A1 Immediate protection against pathogens via mva |
| 11/06/2008 | CA2676808A1 Induction of dendritic cell development with macrophage-colony stimulating factor (m-csf) |
| 11/06/2008 | CA2669049A1 Binary epitope antibodies and b cell superantigen immune stimulants |
| 11/05/2008 | EP1988395A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
| 11/05/2008 | EP1988168A1 Means and methods for providing ribulose bisphosphate-carboxylase-oxygenase with improved properties |
| 11/05/2008 | EP1988166A1 Human Toll-like receptor proteins, related reagents and methods |
| 11/05/2008 | EP1988165A1 Isolated DNA encoding cullin regulator ROC1, isolated proteins encoded by the same, and methods utilizing the same |
| 11/05/2008 | EP1988163A1 Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 11/05/2008 | EP1988161A1 Method of changing fluorescence wavelength of fluoroprotein |
| 11/05/2008 | EP1988102A1 Growth factor homolog ZVEGF3 |
| 11/05/2008 | EP1988101A1 Improvement of factor VIII polypeptide titers in cell cultures |
| 11/05/2008 | EP1988100A1 Derivatives of glucagon-like peptide-2 and their therapeutic use |
| 11/05/2008 | EP1988099A2 Bacillus thuringiensis insecticidal proteins |
| 11/05/2008 | EP1988097A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 11/05/2008 | EP1987845A2 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor. |
| 11/05/2008 | EP1987843A2 Method for solubilising peptide mixtures |
| 11/05/2008 | EP1987836A1 Protective staphylococcus aureus vaccine based on cell wall-associated proteins |
| 11/05/2008 | EP1987357A1 Polypeptides recognized by anti-trichinella antibodies, and uses thereof |
| 11/05/2008 | EP1987178A2 Method of constructing and screening libraries of peptide structures |
| 11/05/2008 | EP1987161A2 Method to identify cd40-sensitive cells |
| 11/05/2008 | EP1987147A2 Method for producing terpenes and mep-transformed microorganisms therefore |
| 11/05/2008 | EP1987144A1 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh |
| 11/05/2008 | EP1987063A1 Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 11/05/2008 | EP1987062A1 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
| 11/05/2008 | EP1987061A1 Soluble receptors and methods for treating autoimmune or demyelinating diseases |
| 11/05/2008 | EP1987060A2 Synthetic hyperglycosylated, and hyperglycosylated protease-resistant polypeptide variants, oral formulations and methods of using the same |
| 11/05/2008 | EP1987059A2 Adir related polymorphisms and applications thereof |
| 11/05/2008 | EP1987058A1 Soluble il-17rcx4 and methods of using in inflammation |
| 11/05/2008 | EP1987056A1 Novel antimicrobial peptides and use thereof |
| 11/05/2008 | EP1987055A1 Novel antimicrobial peptides and use thereof |
| 11/05/2008 | EP1987052A1 Synthesis of glucagon-like peptide |
| 11/05/2008 | EP1986694A1 Coupling of polypeptides at the c-terminus |
| 11/05/2008 | EP1986682A2 Methods and compositions related to targeting tumors and wounds |
| 11/05/2008 | EP1986681A2 Compositions and methods for modulating hemostasis using variant forms of activated factor v |
| 11/05/2008 | EP1986680A2 Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 11/05/2008 | EP1986676A2 Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments |
| 11/05/2008 | EP1986490A4 Model for muscular dystrophy and cardiomyopathy |
| 11/05/2008 | EP1986490A1 Model for muscular dystrophy and cardiomyopathy |
| 11/05/2008 | EP1986489A2 Npc1l1 orthologues |
| 11/05/2008 | EP1848831A4 Elisa assays using prion-specific peptide reagents |
| 11/05/2008 | EP1728077A4 Method for determination and quantification of radiation or genotoxin exposure |
| 11/05/2008 | EP1696944A4 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 11/05/2008 | EP1526140B1 Potassium-dependent sodium-calcium exchanger |
| 11/05/2008 | EP1465996B1 Raf/ras binding compounds |
| 11/05/2008 | EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof |
| 11/05/2008 | EP1341811B9 Orally ingestible preparation of mistletoe lectins and method |
| 11/05/2008 | EP1233782B1 Eliciting hcv-specific antibodies |
| 11/05/2008 | EP1127104B1 Method for the massive culture of cells producing recombinant human erythropoietin |
| 11/05/2008 | EP0994724B1 Methods and compositions for impairing multiplication of hiv-1 |
| 11/05/2008 | CN101300357A Method for the production of y-linolenic acid and/or stearidonic acid in transgenic brassicaceae and linaceae |
| 11/05/2008 | CN101300355A Chimeric antigen containing hepatitis c virus polypeptide and Fc fragment for eliciting an immune response |
| 11/05/2008 | CN101300353A Insecticidal compositions and methods for making insect-resistant transgenic plants |
| 11/05/2008 | CN101300346A Novel biological substance nesfatin and its related substances and uses thereof |
| 11/05/2008 | CN101300274A Immunomodulatory compositions and uses therefor |
| 11/05/2008 | CN101300271A Collagen receptor I-domain binding modulators |
| 11/05/2008 | CN101300270A Non-activated Wnt inhibition polypeptides and method for preparing the same |
| 11/05/2008 | CN101300269A Mecano growth factor peptides and their use |
| 11/05/2008 | CN101300268A Novel bacterial proteins with pesticidal activity |
| 11/05/2008 | CN101300024A Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| 11/05/2008 | CN101298613A Transforming growth factor alpha-HII |
| 11/05/2008 | CN101298607A Production method of recombinant human follicle-stimulating growth hormone |
| 11/05/2008 | CN101298478A Method for detecting and purifying CD8+T lymphocyte populations, specific of peptides present in context of hla |
| 11/05/2008 | CN101298477A Novel insulin derivates and preparation thereof |
| 11/05/2008 | CN101298476A Artificial recombinant tetrad protein A, construction method and use thereof |
| 11/05/2008 | CN101298475A Artificial recombinant penton protein A, construction method and use thereof |
| 11/05/2008 | CN101298474A SEC2 superantigen gene engineering peptides, encoding genes and heterogenetic expression method thereof |
| 11/05/2008 | CN101298473A Conserved neisserial antigens |
| 11/05/2008 | CN100430727C Assaying protein fragments in body fluids |
| 11/05/2008 | CN100430478C CASB618 polynucleotides and polypeptides and their use |
| 11/05/2008 | CN100430477C Hamster EF-1 'alpha' transcriptional regulatory DNA |
| 11/05/2008 | CN100430476C Tumor-lysing virus growing selectively in tumor cells |
| 11/05/2008 | CN100430475C Alga-origin promoter, intron and terminator |
| 11/05/2008 | CN100430420C Human CDR-grafted antibodies and antibody fragments thereof |
| 11/05/2008 | CN100430417C Transferin (Tf)- nerve growth factor (NGF) conjugate preparation method |
| 11/05/2008 | CN100430416C New alpha - conantokins, coded polynucleotide and application |
| 11/05/2008 | CN100430415C Thinopyrum intermedium ERF-transcription factor and its coding gene and use |
| 11/04/2008 | US7446244 Soybean cultivar 6408448 |
| 11/04/2008 | US7446242 Plants with improved morphogenesis and method of constructing the same |
| 11/04/2008 | US7446241 Using vector transformation to generate transgenic plants with enhanced resistance to drought and high environments |
| 11/04/2008 | US7446192 Gene participating in acetic acid tolerance, acetic acid bacteria bred using the gene, and process for producing vinegar with the use of the acetic acid bacteria |
| 11/04/2008 | US7446191 Expression vector comprising nucleotide sequences coding t-cell receptor for use in generation of monoclonal antibody for treatement of cell proliferative disorders |
| 11/04/2008 | US7446190 Nucleic acids encoding chimeric T cell receptors |
| 11/04/2008 | US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression |
| 11/04/2008 | US7446185 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders |
| 11/04/2008 | US7446183 Fusion protein comprising growth hormone and growth hormone receptor |
| 11/04/2008 | US7446181 Antibodies that bind human Dickkopf-1 proteins |
| 11/04/2008 | US7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto |